The Effect of Coenzyme Q10 on Hearing and Tinnitus Characteristics of Chronic Tinnitus Patients
- Conditions
- Tinnitus
- Registration Number
- NCT02353650
- Lead Sponsor
- University Hospital, Antwerp
- Brief Summary
The study is a randomised double-blinded trial. A group of 40 tinnitus patients with a naturally low Q10 level will be selected out of a preselected group of 160 screened out of a pre-existed database or patients which visited the ENT-consultation. The 40 patients with the lowest level will be asked to take 2 months Q10 (n=20) or the placebo (n=20). To evaluate the effect on hearing and tinnitus characteristic; audiometric test, tinnitus analysis and auditory evoked responses will be used as outcome measurements.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
- chronic non-pulsatile tinnitus > 3 months
- tinnitus has a clear otological cause
- age > 18 years
- pulsatile tinnitus
- persons who take already Q10
- pregnancy
- cervical tinnitus
- holocranial tinnitus
- depression
- mental of neurological disorders
- history of chemotherapy
- middle ear diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tinnitus Functional Index 2 months
- Secondary Outcome Measures
Name Time Method Hospital Anxiety and Depression Scale 2 months Hyperacusis Questionnaire 2 months Audiometric tresholds test 2 months Tinnitus Analysis _ loudness matches 2 months Tinnitus Analysis_Minimal masking level 2 months Visual Analogue Scale of loudness 2 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University hospital of Antwerp
🇧🇪Edegem, Antwerp, Belgium